Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$26.4 - $32.56 $21,093 - $26,015
-799 Reduced 0.88%
89,515 $2.42 Million
Q4 2023

Feb 13, 2024

BUY
$23.37 - $28.68 $175,345 - $215,186
7,503 Added 9.06%
90,314 $2.51 Million
Q3 2023

Nov 13, 2023

BUY
$27.17 - $31.97 $79,988 - $94,119
2,944 Added 3.69%
82,811 $2.32 Million
Q2 2023

Aug 04, 2023

BUY
$28.34 - $33.63 $33,157 - $39,347
1,170 Added 1.49%
79,867 $2.5 Million
Q1 2023

May 12, 2023

BUY
$25.31 - $29.02 $39,635 - $45,445
1,566 Added 2.03%
78,697 $2.22 Million
Q4 2022

Feb 10, 2023

SELL
$21.94 - $26.24 $6,165 - $7,373
-281 Reduced 0.36%
77,131 $2.02 Million
Q3 2022

Nov 14, 2022

BUY
$22.0 - $31.87 $24,068 - $34,865
1,094 Added 1.43%
77,412 $1.73 Million
Q2 2022

Aug 12, 2022

SELL
$26.4 - $30.54 $87,832 - $101,606
-3,327 Reduced 4.18%
76,318 $2.27 Million
Q1 2022

May 13, 2022

SELL
$23.07 - $27.99 $129,330 - $156,911
-5,606 Reduced 6.58%
79,645 $2.1 Million
Q4 2021

Feb 11, 2022

SELL
$21.47 - $32.08 $54,748 - $81,804
-2,550 Reduced 2.9%
85,251 $1.98 Million
Q3 2021

Nov 12, 2021

SELL
$23.37 - $32.13 $48,796 - $67,087
-2,088 Reduced 2.32%
87,801 $2.71 Million
Q2 2021

Aug 13, 2021

BUY
$18.78 - $25.15 $1.65 Million - $2.21 Million
88,001 Added 4661.07%
89,889 $2.2 Million
Q1 2021

May 07, 2021

SELL
$18.21 - $23.2 $2,858 - $3,642
-157 Reduced 7.68%
1,888 $35,000
Q4 2020

Feb 12, 2021

SELL
$15.39 - $22.1 $169 - $243
-11 Reduced 0.54%
2,045 $41,000
Q3 2020

Nov 04, 2020

SELL
$16.16 - $20.66 $96 - $123
-6 Reduced 0.29%
2,056 $34,000
Q2 2020

Aug 12, 2020

SELL
$13.31 - $19.41 $6,348 - $9,258
-477 Reduced 18.79%
2,062 $40,000
Q1 2020

May 04, 2020

BUY
$13.06 - $21.24 $1,240 - $2,017
95 Added 3.89%
2,539 $37,000
Q4 2019

Feb 05, 2020

SELL
$17.29 - $21.74 $1,417 - $1,782
-82 Reduced 3.25%
2,444 $50,000
Q2 2019

Aug 23, 2019

BUY
$21.47 - $37.33 $54,233 - $94,295
2,526 New
2,526 $57,000
Q2 2019

Aug 13, 2019

SELL
$21.47 - $37.33 $156,430 - $271,986
-7,286 Closed
0 $0
Q1 2019

May 06, 2019

SELL
$28.4 - $36.49 $3,606 - $4,634
-127 Reduced 1.71%
7,286 $266,000
Q4 2018

Feb 13, 2019

SELL
$27.94 - $44.61 $11,455 - $18,290
-410 Reduced 5.24%
7,413 $219,000
Q2 2018

Aug 08, 2018

BUY
$40.56 - $51.36 $9,937 - $12,583
245 Added 3.23%
7,823 $322,000
Q1 2018

May 07, 2018

SELL
$53.61 - $67.26 $7,130 - $8,945
-133 Reduced 1.72%
7,578 $439,000
Q4 2017

Feb 09, 2018

BUY
$47.69 - $55.39 $367,737 - $427,112
7,711
7,711 $422,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.55B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.